# Document Change Summary

**Generated:** 2024-01-15T10:30:00Z
**Document Type:** NDA
**Original File:** Acme-NDA-v1.docx

## Executive Summary

This NDA has been modified with 12 changes across 3 sections.
The primary changes relate to the confidentiality period and
permitted disclosures. Two medium-risk items were identified.

## Change Statistics

| Metric        | Count |
| ------------- | ----- |
| Total Changes | 12    |
| Additions     | 8     |
| Deletions     | 3     |
| Modifications | 1     |

## Changes by Section

### Section 2: Confidential Information

- Extended definition to include "derivative works"
- Added carve-out for publicly available information

### Section 4: Permitted Disclosures

- Added exception for regulatory requirements
- Clarified notice requirements

# Risk Analysis Report

**Overall Risk Score:** 45/100
**High Risk Items:** 0
**Medium Risk Items:** 2

## Flagged Items

### 1. Confidentiality Duration
**Risk Level:** Medium
**Section:** Section 5

Duration extended from 3 years to 5 years post-termination.

**Recommendation:** Confirm this extended period is
commercially acceptable.

### 2. Return of Information
**Risk Level:** Medium
**Section:** Section 6

Added requirement to certify destruction in writing.

**Recommendation:** Verify compliance process can meet
this new requirement.